ImmuCell Co. (NASDAQ:ICCC – Get Free Report) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $4.97 and traded as high as $5.29. ImmuCell shares last traded at $5.15, with a volume of 6,004 shares changing hands.
ImmuCell Stock Down 0.3 %
The stock’s fifty day moving average price is $4.89 and its 200-day moving average price is $4.97. The company has a current ratio of 3.59, a quick ratio of 1.37 and a debt-to-equity ratio of 0.42.
ImmuCell (NASDAQ:ICCC – Get Free Report) last released its earnings results on Monday, November 13th. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter. The business had revenue of $5.40 million for the quarter. ImmuCell had a negative return on equity of 22.63% and a negative net margin of 38.70%.
Institutional Inflows and Outflows
ImmuCell Company Profile
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E.
- Five stocks we like better than ImmuCell
- When to Sell a Stock for Profit or Loss
- Ulta Beauty set for a breakout to new highs
- Stock Average Calculator
- Exxon and Chevron ready to rally: The floor is in for big oil
- Investing in the Best Airline Stocks
- Analysts jumped on this stock ahead of earnings; markets love it
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.